The short answer
Confirm what this HAB_Datura product contains before applying a Datura interaction warning. Raw Datura poisoning evidence does not establish the concentration or effects of this preparation.
What this answer covers
HAB_Datura product with unverified dilution and active-alkaloid concentration.
- Supplement or preparation
- HAB_Datura stramonium
- Medication ingredient
- orphenadrine
Why the effects could add up
Orphenadrine has anticholinergic or atropine-like effects. Active plant alkaloids can affect the same functions, making bowel, bladder, vision and mental-state symptoms relevant.
What the human report establishes
The original report describes plant poisoning in children, with anticholinergic symptoms. It supports concern about active plant material, but does not measure this medicine combination or the risk at an adult supplement dose.
The product identity matters
HAB labeling alone does not establish whether the preparation contains clinically relevant alkaloid amounts. Raw seeds cannot stand in for an unidentified dilution.
Act on symptoms rather than guessing a gap
Have the exact product checked before use. A short timing gap is not an established way to prevent overlapping effects. Seek urgent care for marked confusion, inability to urinate, severe abdominal swelling or pain, or a painful red eye with vision change.
Evidence and practical considerations
Side effects & toxicity
HAB product identity and alkaloid concentration unresolved; raw Datura case cannot validate original exact-product claim.
- Exact scope
- HAB_Datura product with unverified dilution and active-alkaloid concentration. with Oral orphenadrine citrate extended-release tablets; fixed aspirin/caffeine combination distinguished.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed orphenadrine
Anticholinergic effects, dizziness, drowsiness and impaired driving; tachycardia and urinary retention precautions.
How this applies: Exact orphenadrine RxCUI 7715 IN, with stated salt/formulation/route bridge.
No exact supplement-combination incidence or validated protective spacing; salt, route and release form limits apply.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One young child after Datura stramonium seed ingestion.
An anticholinergic toxidrome with agitation, dilated pupils, tachycardia and seizures was reported.
How this applies: Interpreted for orphenadrine only within the stated exact preparation and endpoint limits.
Plant poisoning in children, not an exact medication co-use study or adult supplement risk estimate. HAB dilution/concentration unverified.
Research assessment: · Open full citations ↗
Side effects & toxicity
If a product contains pharmacologically active Datura stramonium alkaloids, additive anticholinergic effects with orphenadrine are a conditional concern.
- Exact scope
- Confirmed active-alkaloid Datura stramonium preparation. with Oral orphenadrine citrate extended-release tablets; fixed aspirin/caffeine combination distinguished.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No exact-pair incidence or universally protective timing interval.
Factors that may matter: Preparation; Dose; Other medicines.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed orphenadrine
Anticholinergic effects, dizziness, drowsiness and impaired driving; tachycardia and urinary retention precautions.
How this applies: Exact orphenadrine RxCUI 7715 IN, with stated salt/formulation/route bridge.
No exact supplement-combination incidence or validated protective spacing; salt, route and release form limits apply.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One young child after Datura stramonium seed ingestion.
An anticholinergic toxidrome with agitation, dilated pupils, tachycardia and seizures was reported.
How this applies: Interpreted for orphenadrine only within the stated exact preparation and endpoint limits.
Plant poisoning in children, not an exact medication co-use study or adult supplement risk estimate. HAB dilution/concentration unverified.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Prepared exact orphenadrine article with formulation-specific evidence and uncertainty. |
Article revision: a2925e0a57265277
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.